كينيا - الإنجليزية - Pharmacy and Poisons Board

macleods pharmaceuticals limited 304, atlanta arcade, marol church road, andheri - olmesartan medoxomil 40 mg, amlodipine 5 mg and… - film-coated tablet - olmesartan medoxomil 40 mg, amlodipine 5 mg and… - antihypertensives

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

amneal pharmaceuticals llc - olmesartan medoxomil (unii: 6m97xtv3hd) (olmesartan - unii:8w1iqp3u10) - olmesartan medoxomil tablets are indicated for the treatment of hypertension in adults and children six years of age and older, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with olmesartan medoxomil tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s join

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

medo pharmaceuticals limited - docusate sodium - syrup

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

medo pharmaceuticals limited - docusate sodium - 1 per cent

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - olmesartan medoxomil, quantity: 20 mg - tablet - excipient ingredients: lactose monohydrate; hyprolose; microcrystalline cellulose; stearic acid; magnesium stearate; titanium dioxide; hypromellose; purified talc - olmesartan medoxomil is indicated for the treatment of hypertension.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg - tablet - excipient ingredients: magnesium stearate; lactose monohydrate; hyprolose; stearic acid; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc - olmesartan medoxomil is indicated for the treatment of hypertension.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg - tablet - excipient ingredients: magnesium stearate; stearic acid; lactose monohydrate; hyprolose; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc - olmesartan medoxomil is indicated for the treatment of hypertension.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - olmesartan medoxomil, quantity: 20 mg - tablet - excipient ingredients: stearic acid; hyprolose; microcrystalline cellulose; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; purified talc - olmesartan medoxomil is indicated for the treatment of hypertension.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 25 mg; amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty mg) - tablet - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - sevikar hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty mg); olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: magnesium stearate; croscarmellose sodium; pregelatinised maize starch; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - sevikar hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy